Longboard Pharmaceuticals Inc’s (LBPH) Stock: A -9.96% Simple Moving Average for the Past 20 Days

The stock of Longboard Pharmaceuticals Inc (LBPH) has gone down by -9.90% for the week, with a -15.60% drop in the past month and a -27.81% drop in the past quarter. The volatility ratio for the week is 7.21%, and the volatility levels for the past 30 days are 7.27% for LBPH. The simple moving average for the past 20 days is -9.96% for LBPH’s stock, with a 66.26% simple moving average for the past 200 days.

Is It Worth Investing in Longboard Pharmaceuticals Inc (NASDAQ: LBPH) Right Now?

The stock has a 36-month beta value of 1.28. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for LBPH is 33.21M, and at present, short sellers hold a 11.27% of that float. On April 04, 2024, the average trading volume of LBPH was 796.03K shares.

LBPH) stock’s latest price update

Longboard Pharmaceuticals Inc (NASDAQ: LBPH)’s stock price has dropped by -8.39 in relation to previous closing price of 19.78. Nevertheless, the company has seen a loss of -9.90% in its stock price over the last five trading days. Zacks Investment Research reported 2024-01-05 that Longboard Pharmaceuticals, Inc. (LBPH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Analysts’ Opinion of LBPH

Many brokerage firms have already submitted their reports for LBPH stocks, with Citigroup repeating the rating for LBPH by listing it as a “Buy.” The predicted price for LBPH in the upcoming period, according to Citigroup is $40 based on the research report published on February 16, 2024 of the current year 2024.

Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see LBPH reach a price target of $35, previously predicting the price at $16. The rating they have provided for LBPH stocks is “Overweight” according to the report published on October 24th, 2023.

B. Riley Securities gave a rating of “Buy” to LBPH, setting the target price at $13 in the report published on April 27th of the previous year.

LBPH Trading at -14.67% from the 50-Day Moving Average

After a stumble in the market that brought LBPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.63% of loss for the given period.

Volatility was left at 7.27%, however, over the last 30 days, the volatility rate increased by 7.21%, as shares sank -11.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -27.58% lower at present.

During the last 5 trading sessions, LBPH fell by -9.90%, which changed the moving average for the period of 200-days by +133.51% in comparison to the 20-day moving average, which settled at $20.01. In addition, Longboard Pharmaceuticals Inc saw 200.50% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at LBPH starting from ARENA PHARMACEUTICALS INC, who sale 3,978,540 shares at the price of $24.25 back on Jan 25 ’24. After this action, ARENA PHARMACEUTICALS INC now owns 0 shares of Longboard Pharmaceuticals Inc, valued at $96,479,595 using the latest closing price.

Stock Fundamentals for LBPH

The total capital return value is set at -1.39. Equity return is now at value -106.30, with -89.72 for asset returns.

Based on Longboard Pharmaceuticals Inc (LBPH), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -107.09. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 112.17.

Currently, EBITDA for the company is -56.75 million with net debt to EBITDA at 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.14.

Conclusion

To sum up, Longboard Pharmaceuticals Inc (LBPH) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts